Two makers of breathing machines have told the US Food and Drug Administration that it must address language in its draft Quality Management System Regulation (QMSR) that the manufacturers say would place onerous traceability requirements on most medical devices.
24 May is the deadline for commenting on the proposed QMSR, which will replace the FDA’s Quality System Regulation....